HSPD1 and diabetes mellitus: The mycobacterial Hsp65 as a DNA vaccine construct (DNAhsp65) has also been the focus of tolerogenic immune interventions aimed at preventing and treating-mediated diseases such as experimental autoimmune encephalitis, arthritis, atherosclerosis and diabetes [11–14].